This matters because photobiomodulation (PBM) research is fundamentally dose-dependent. According to a 2019 review published in the Journal of Biomedical Optics, there is still no universal consensus on optimal irradiance parameters, and wide variation in reported results often traces back to inconsistent measurement and documentation of dosimetric parameters, including irradiance, treatment distance, and surface area exposed.

The dose a client receives is calculated as:

Dose (J/cm²) = Irradiance (mW/cm²) x Time (seconds) / 1,000

Change the irradiance input by fudging the measurement distance, and the calculated dose changes proportionally. A device that delivers 65 mW/cm² at contact delivers meaningfully less at six inches, and even less at 12 inches. When different manufacturers measure at different distances and present only the headline number, buyers cannot make apples-to-apples comparisons.

The commercial red light therapy industry does not yet have a single mandatory measurement protocol enforced across all product listings. The most relevant technical framework, IEC 60601-2-57:2023, sets safety and performance requirements for non-laser light source equipment used to create photobiological effects, but it governs output uniformity and safety, not the specific distance at which marketing claims must be stated.

That gap is where the confusion lives, and it is where buyers get misled.

Why Do Irradiance Claims Vary So Wildly Across the Industry?

The short answer is that irradiance obeys the inverse square law. Double the distance between the light source and the measurement point, and you roughly quarter the irradiance reading. That means a manufacturer can choose the measurement distance strategically to publish the highest possible number.

Here are the four most common sources of variation in published irradiance claims:

1. Measurement distance. One company measures at contact (0 inches). Another measures at six inches. A third measures at 12 inches. All three could be measuring the same power output from the same LED array and publishing dramatically different mW/cm² figures.

2. Single-LED vs. panel-averaged measurement. Some companies measure the irradiance at a single high-output LED emitter, then report that number as the device's irradiance. The average across the full treatment surface, including lower-intensity areas between emitters, may be substantially lower. A clinically honest figure averages irradiance across the entire treatment area.

3. Measurement instrument type. Solar irradiance meters, uncalibrated photodiodes, and cosine-corrected optical power meters all produce different readings. Without a calibrated optical power meter, the figure on the spec sheet is an estimate at best. In a 2022 study in PLOS ONE evaluating low-power laser devices, researchers found meaningful variability in measured vs. rated power output across clinical devices, underscoring the importance of calibrated measurement protocols.

4. Angle of incidence. Light measured perpendicular to the sensor surface reads higher than light hitting the sensor at an angle. Bed configurations, curved panels, and angled emitter arrays all affect real-world delivery versus the single-point spec on a data sheet.

The result is a market where a device marketed at "200 mW/cm²" might actually deliver less effective dose at treatment distance than a device marketed at 65 mW/cm² measured at contact, because the 65 mW/cm² figure is the honest number at the body.

How Do Distance and Measurement Point Change the Numbers?

The table below illustrates how the same hypothetical commercial red light therapy bed could be marketed at dramatically different irradiance figures depending solely on measurement methodology. By combining different distances with uncalibrated meters or isolating a single "hot spot" LED peak, a manufacturer can twist the exact same physical output into massive, inflated numbers.

Note: The figures above are illustrative, showing the principle of inverse-square decay and peak-cone single-point inflation. Real device readings will vary by optical design. The point stands: the same physical output can be advertised at five different numbers depending on methodology.

BBS measures the OvationULT at 65 mW/cm² at contact, using a calibrated optical power meter, averaged across the full treatment surface. That is the number a client's body actually receives when the bed is used as designed.

What Is the Right Methodology for Measuring Commercial RLT Irradiance?

A rigorous, buyer-verifiable irradiance measurement protocol requires four documented parameters:

Distance: Stated precisely in inches or centimeters from the LED emitter surface to the measurement point.

Instrument: A calibrated optical power meter with a known calibration date. Instruments should be traceable to a recognized standards body. The IEC 60601-2-57:2023 standard framework for non-laser optical medical equipment specifies requirements for output performance documentation and uniformity measurement.

Measurement area: Either single-point (peak) or surface-averaged. Surface-averaged across the full treatment zone is the clinically relevant figure.

Measurement conditions: Whether the device is measured in contact with a surface, in open air, at what ambient temperature, and whether the device was at steady-state operating temperature when measured.

When these four parameters are documented, buyers can compare devices honestly. When any parameter is missing, the spec sheet number is not meaningful for purchase decisions.

BBS's position, consistent across 13 years of commercial deployment, is that irradiance should be stated at contact, averaged across the treatment surface, measured with a calibrated optical power meter. The OvationULT delivers 65 mW/cm² under those conditions. That standard has been validated in commercial environments from Canyon Ranch to Four Seasons properties.

What Questions Should You Ask Any Red Light Therapy Manufacturer?

Before requesting a quote or evaluating a purchase, ask every manufacturer the same five questions. Their answers will tell you more than any spec sheet.

Question 1: At what distance from the LED surface was the irradiance measured?

If the answer is anything other than "at contact" or a specific stated distance in inches or centimeters, the number is not auditable.

Question 2: Was irradiance measured with a calibrated optical power meter? What instrument was used and what is its calibration date?

A calibrated instrument traceable to a standards body produces a defensible number. An uncalibrated solar meter or a manufacturer's in-house reading without documented methodology does not.

Question 3: Is the stated irradiance a peak reading from a single LED, or an average across the full treatment surface?

Full-surface averages represent real-world dose delivery. Peak single-point readings do not.

Question 4: What is the irradiance at contact? At six inches? At 12 inches?

Any manufacturer with honest measurement data should be able to provide the full decay curve. If they cannot, the headline number may have been chosen for marketing, not accuracy.

Question 5: Is the device FDA registered with the CDRH? What is the facility registration number and product code?

For commercial medical devices, FDA registration is verifiable in the FDA CDRH Device Registration and Listing database. BBS's FDA registration number is #3010627475. The OvationULT carries the ILY product code (Infrared Lamp for Heating), consistent with its cleared scope of use.

How Does BBS Measure the OvationULT's 65 mW/cm²?

The OvationULT is measured at contact across the full treatment surface using a calibrated optical power meter. The 65 mW/cm² figure represents the averaged irradiance a client receives when the bed is used as designed, with the body in contact with or immediately adjacent to the treatment surface.

This methodology aligns with the contact-measurement approach referenced in commercial PBM research. The PLOS ONE laser device evaluation study used calibrated power meters (Thorlabs PM100D with S130C sensor) to document actual vs. rated output, the same category of measurement rigor BBS applies to the OvationULT.

The practical implication for operators: when you book a client on the OvationULT, they receive 65 mW/cm². Not 65 mW/cm² "up to" or "at optimal positioning." At contact. Every session.

The OvationULT runs on a 120V standard outlet, eliminating the electrical infrastructure cost that 240V commercial devices impose. It carries a 5-year white-glove warranty. Properties including Four Seasons, Fairmont, Bellagio, Aria, and Canyon Ranch have deployed it in active commercial rotation because the spec is what it claims to be and the equipment holds up.

What Does a Full Due Diligence Checklist Look Like for RLT Equipment Buyers?

Use this checklist before any commercial red light therapy equipment purchase. Every item should have a documented, verifiable answer from the manufacturer.

Operators who run through this checklist with every vendor will find quickly that not all manufacturers can answer every question. The ones who cannot are, by definition, asking you to trust a number they have not fully documented.

FAQ: Red Light Therapy Irradiance Specs

What is irradiance in red light therapy and why does it matter?

Irradiance, measured in mW/cm², quantifies the optical power delivered to a unit of skin surface area. It is the primary input variable in calculating therapeutic dose (J/cm²). Without a precise, distance-specific irradiance figure, you cannot calculate the actual energy dose a client receives in a given session time. According to a review published in the Journal of Biomedical Optics, inconsistent documentation of irradiance parameters is one of the primary reasons PBM research produces variable results across studies.

Can the same device produce different irradiance readings?

Yes, easily. True irradiance decreases with distance from the source due to the inverse square law. A device measured honestly at contact will naturally show a higher mW/cm² than at six inches. However, many manufacturers use uncalibrated solar meters that improperly capture overlapping light beams at a distance, creating a false "hot spot" reading that makes their six inch measurement look artificially higher. Manufacturers who publish only a headline number without specifying distance and instrument methodology make accurate comparison impossible.

What is the IEC 60601-2-57 standard and why is it relevant?

IEC 60601-2-57:2023 is the international standard governing safety and essential performance requirements for non-laser light source equipment used to create photobiological effects. It covers output uniformity, optical radiation hazard classification, and documentation requirements. While it does not mandate a single marketing-claim measurement distance, its output performance requirements demand that manufacturers can document and verify their device's light output in a consistent, reproducible way.

What is the difference between irradiance and fluence (energy density)?

Irradiance (mW/cm²) is a rate: optical power per unit area at a given moment. Fluence, or energy density (J/cm²), is the total energy delivered per unit area over a treatment session. Fluence = Irradiance (W/cm²) x Time (seconds). To compare treatment protocols across devices, you need both the irradiance (at a stated, consistent distance) and the session duration. A lower irradiance device can deliver equivalent fluence if the session is proportionally longer, but this requires the operator to know the honest irradiance figure to set session time correctly.

What irradiance does the BBS OvationULT deliver?

The OvationULT delivers 65 mW/cm² measured at contact, averaged across the full treatment surface, using a calibrated optical power meter. This is the figure used to guide session time for commercial operators running the OvationULT in active spa, hotel, and wellness programs.

How do I verify a manufacturer's FDA registration claim?

The FDA CDRH Device Registration and Listing database is publicly searchable. Enter the facility name or stated registration number and confirm the listing is current, the product code matches the device category, and the registration status is active. BBS's registration number is #3010627475.

Does higher irradiance always mean a better device?

Not necessarily. Irradiance that is verified, consistently measured, and matched to session time produces a reproducible therapeutic dose. An unverified high number that cannot be reproduced at the measurement conditions stated is not useful. The question is not which device posts the largest number, but which device delivers a documented, consistent, honest figure that operators can use to build a repeatable protocol.

Internal Resources

What Does "FDA Registered" Actually Mean for a Red Light Therapy Device?

How Does Red Light Therapy Work? A Commercial Operator's Guide to the Science

Red Light Therapy Pricing Models: Per Session, Membership, and Package Structures

What the Peer-Reviewed Research Actually Says About Photobiomodulation

Photobiomodulation Mechanism: Cytochrome C Oxidase, ATP, and What It Means for Commercial Operators

External Citations

Heiskanen, V., and Hamblin, M. (2019). Review of light parameters and photobiomodulation efficacy. Journal of Biomedical Optics. https://pmc.ncbi.nlm.nih.gov/articles/PMC8355782/

Pinheiro, A. et al. (2022). Laser light sources for photobiomodulation: The role of power and stability. PLOS ONE. https://pmc.ncbi.nlm.nih.gov/articles/PMC8967059/

IEC 60601-2-57:2023. Medical electrical equipment, Part 2-57: Particular requirements for the basic safety and essential performance of non-laser light source equipment intended for therapeutic, diagnostic, monitoring, cosmetic and aesthetic use. International Electrotechnical Commission. https://webstore.iec.ch/en/publication/73147

FDA CDRH Device Registration and Listing Database. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/device-registration-and-listing/device-registration-and-listing-database-search

Fekrazad, R. et al. (2020). Photobiomodulation Dose Parameters in Dentistry: A Systematic Review. Dentistry Journal. https://pmc.ncbi.nlm.nih.gov/articles/PMC7711492/

For a deeper breakdown of red light therapy economics inside a medspa, see our companion post on How to Add Red Light Therapy to Your Medspa.

How do you avoid discounting and protect price discipline?

Discounting is the single fastest way to compress revenue per session. The pattern is consistent across operator interviews. A new program launches with an introductory offer. The offer extends. New clients learn that prices are flexible. Repricing back to standard rates produces churn. The program never recovers full margin.

The discipline that prevents this pattern has three parts.

Part one: cap introductory offers at a fixed window. A free first session or a 50 percent discount on the first package is fine for the first 90 days of a launch. After 90 days, the offer ends. New clients see standard pricing. Returning clients who missed the offer learn that promotions are time-bound, not permanent.

Part two: avoid Groupon and daily deal sites. These channels train clients to expect 70 to 80 percent discounts as the default price. Acquiring a client through Groupon and then asking them to pay full price for a follow up package produces high churn and bad reviews.

Part three: make package and membership the default sale, not the per session price. Front desk training matters here. The standard offer at the consultation should be a 10 pack or a membership, not a single session. The per session price exists for the walk-in who is genuinely testing, not as the primary product.

How do you reprice a program that has compressed margins?

Repricing a program that has trained itself into discount territory takes patience.

The first step is documenting the current blend. Run a 30 day report from the booking system. Pull average revenue per session across all clients, all three pricing layers, and all promotional categories. The blended number is usually 20 to 40 percent below where it should be, and the gap shows where the discounting concentrated.

The second step is repricing the membership and package SKUs. Existing membership and package clients keep their current rates for the duration of their commitment. New clients see the new rates from the repricing date. Communicate the change clearly. Repricing without communication produces churn.

The third step is removing the standing discounts. A 20 percent off code that has been on the website for 18 months is not a promotion. It is the price. Removing it lifts revenue per session immediately on new clients while protecting current clients on their existing terms.

The fourth step is rebuilding the front desk script. The standard offer becomes the package or membership. The per session price is offered only on direct request. This shifts the average sale up without aggressive selling.

Most programs see a 15 to 30 percent lift in revenue per session within 90 days of a disciplined repricing.

How does the OvationULT support a high revenue per hour pricing model?

The OvationULT is built for commercial throughput. Three specifications matter for revenue per hour.

First, irradiance at 65 milliwatts per square centimeter at the contact surface supports calibrated 12 to 20 minute session protocols within published dose response evidence. Lower irradiance devices require longer sessions to deliver comparable doses, which compresses throughput and revenue per hour.

Second, the bed runs on a 120 volt standard outlet. Many competing commercial beds require 240 volt service or dedicated electrical work that adds installation cost and limits room placement flexibility. The 120 volt standard simplifies room conversion and keeps the bed runnable in standard medspa, gym, and recovery center electrical layouts.

Third, the 5 year white glove warranty eliminates the maintenance variability that compresses payback math on lower-tier devices. White glove service means parts, labor, and on-call response over the full warranty window.

Body Balance System is FDA registered under registration number 3010627475, with the OvationULT listed under the ILY product code. Trust installations include the Bellagio, Aria, Four Seasons, Fairmont, and Canyon Ranch.

For the full economic case, see The Complete Guide to Commercial Red Light Therapy.

FAQ

What is a typical price for a single red light therapy session in 2026?

Per session pricing in commercial settings runs $40 to $75 for a 12 to 20 minute full body session. Luxury hospitality and medical aesthetics environments can run $75 to $100 per session.

What is the typical price for a 10 session red light therapy package?

A 10 session package typically runs $300 to $500, bringing the per session rate to $30 to $50. Package pricing is the most common commercial model because it balances revenue per session with utilization.

Should I offer unlimited red light therapy memberships?

Unlimited memberships work well for red light therapy because variable cost per session is low. The pricing decision is about retention margin, not session margin. A typical structure is $99 to $199 per month for unlimited or capped weekly access.

How many clients per hour can one commercial red light therapy bed serve?

Two clients per operating hour is the realistic steady state ceiling at 15 minute sessions plus 15 minute transitions. Three per hour is possible in short bursts but not sustainable across a full operating day.

How do I avoid discounting my red light therapy pricing?

Cap introductory offers at 90 days, avoid Groupon and daily deal sites, and make packages or memberships the default sale at the front desk rather than per session pricing.

What is a realistic year one revenue for a commercial red light therapy bed?

At moderate utilization (50 percent of throughput ceiling) and a $40 blended revenue per session, a single bed produces roughly $48,000 in year one. Year two and beyond, well-run programs reach $84,000 to $120,000 in annual revenue.

Internal Links

How to Add Red Light Therapy to Your Medspa: Revenue, ROI, and Implementation

The Complete Guide to Commercial Red Light Therapy

What FDA Registered Actually Means in Red Light Therapy

How Does Red Light Therapy Work?

External Citations

American Med Spa Association: 2025 Industry Report - Industry benchmarks for medspa pricing and membership economics.

International Health, Racquet and Sportsclub Association (IHRSA) industry data - Membership economics and retention research applicable to recurring service models.

FDA Establishment Registration and Device Listing Database - Public verification of manufacturer FDA registration status.

FDA CDRH Product Classification Database - Official source for ILY product code and indications.

U.S. Energy Information Administration: Commercial Electricity Rates - Reference for variable cost calculations on commercial equipment.

First, it sets the boundary for client conversations. An operator who cites peer-reviewed evidence accurately builds trust. An operator who overstates findings creates exposure. The FTC has issued warning letters to wellness businesses that claim therapeutic benefits beyond their device's regulatory scope (FTC Health Products Compliance Guidance). Knowing what the evidence supports, and what it does not, is the cleanest defense.

Second, it informs equipment selection. Studies use specific wavelengths, irradiance levels, and dose ranges. Equipment that operates outside those parameters delivers something different from what the studies tested. A bed marketed at 850 nanometers behaves differently from one marketed at 660 nanometers, and the published evidence for each wavelength is not interchangeable.

Third, it stabilizes pricing conversations. A client asking why a 15 minute session costs $50 deserves more than a marketing claim. Citing a specific dose response study and explaining why session length is calibrated to that evidence shifts the conversation from "trust me" to "here is the evidence." That shift matters for membership renewals.

The five studies below are starting points, not the entire literature. An operator who reads these five and understands them is better prepared than 95 percent of the market.

Study 1: What did Karu's mechanism research establish about cytochrome c oxidase?

Citation: Karu, T. (1999). Primary and secondary mechanisms of action of visible to near-IR radiation on cells. Journal of Photochemistry and Photobiology B: Biology, 49(1), 1 to 17.

Study type: Review paper synthesizing mechanism research

What it established: Tiina Karu's foundational work identified cytochrome c oxidase, the terminal enzyme in the mitochondrial electron transport chain, as a primary photoacceptor for red and near-infrared light. The paper proposed that photon absorption by cytochrome c oxidase increases ATP production and modulates downstream cellular signaling. This mechanism is now the most widely cited explanation for the cellular effects of photobiomodulation (Journal of Photochemistry and Photobiology B).

What it does not prove: The Karu mechanism is well-supported in cell culture and in vitro work. It does not prove any specific clinical outcome at the whole-body level. The path from "ATP production increases at the cellular level" to "this client's joint pain improves" requires additional clinical evidence for each application.

How an operator should reference it: "Published mechanism research suggests that red and near-infrared wavelengths interact with cytochrome c oxidase to support cellular energy production." This is accurate, attributed to research, and stays within ILY scope.

Study 2: What did the Huang dose response review reveal about the biphasic curve?

Citation: Huang, Y. Y., Chen, A. C., Carroll, J. D., & Hamblin, M. R. (2009). Biphasic dose response in low level light therapy. Dose-Response, 7(4), 358 to 383.

Study type: Review paper analyzing dose response patterns across the published literature

What it established: The Huang paper documented what photobiomodulation researchers call the biphasic dose response. Across multiple published studies, biological response increased with light dose up to a peak, then decreased as dose continued to increase. More light was not better past the inflection point. The paper established that effective photobiomodulation requires a calibrated dose, not a maximum dose (Dose-Response journal).

What it does not prove: The biphasic curve is well-documented in mechanism studies and selected clinical trials. The exact peak dose for each application, tissue type, and individual is not established. Operators should treat published dose ranges as informed starting points, not precise prescriptions.

Why it matters for commercial protocols: Session length, irradiance, and frequency all factor into total dose. A high irradiance bed at 65 milliwatts per square centimeter delivers a calibrated dose in a 12 to 20 minute session. A low irradiance device may require a longer session to deliver the same dose, and may still fall short of the documented effective range.

Study 3: What did the Hamblin near-infrared review establish about tissue penetration?

Citation: Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337 to 361.

Study type: Review paper covering mechanism, wavelength selection, and inflammation research

What it established: Hamblin synthesized published evidence on tissue penetration depth for red and near-infrared wavelengths. Red light at 630 to 670 nanometers is absorbed primarily by skin and superficial tissue. Near-infrared light at 810 to 850 nanometers penetrates several millimeters deeper into muscle and connective tissue. The paper also reviewed published evidence on photobiomodulation effects on inflammatory markers in cell culture and animal models (AIMS Biophysics).

What it does not prove: Penetration depth is reasonably well-established in tissue optics. The paper does not prove that deeper penetration always produces better clinical outcomes. The right wavelength depends on the target tissue and the application, not a single "deeper is better" rule.

How an operator should reference it: "Published research on photobiomodulation indicates that 630 to 670 nanometer wavelengths interact primarily with superficial tissue, while 810 to 850 nanometer wavelengths penetrate to deeper muscle and connective tissue." Accurate, sourced, and useful for explaining why a commercial bed combines both wavelength ranges.

Study 4: What did the Ferraresi muscle recovery research show?

Citation: Ferraresi, C., Huang, Y. Y., & Hamblin, M. R. (2016). Photobiomodulation in human muscle tissue: an advantage in sports performance? Journal of Biophotonics, 9(11 to 12), 1273 to 1299.

Study type: Review paper synthesizing muscle and athletic performance research

What it established: The Ferraresi paper reviewed dozens of published studies on photobiomodulation applied to human muscle tissue before, during, and after exercise. The synthesized findings included evidence for reduced post-exercise inflammation markers, faster recovery of muscle force, and reduced delayed onset muscle soreness in selected studies. The paper organized the evidence by study design, dose, and application timing (Journal of Biophotonics).

What it does not prove: Athletic recovery applications have a growing evidence base, but the studies vary in quality. Some are small open label studies. Others are well-designed randomized controlled trials. The Ferraresi review acknowledges this variation and does not claim that photobiomodulation is universally effective for athletic recovery.

Why it matters for commercial operators: This is the citation that supports recovery and athletic positioning, when used responsibly. An operator can reference the published evidence on muscle recovery without claiming that the OvationULT, or any specific commercial bed, treats injuries or accelerates healing. The distinction between "published research suggests" and "this device treats" is the line between compliant and non-compliant marketing.

Study 5: What did the Cochrane review conclude about the limits of current evidence?

Citation: Brosseau, L., Robinson, V., Wells, G., et al. (2005). Low level laser therapy (Classes I, II and III) for treating osteoarthritis. Cochrane Database of Systematic Reviews, (2), CD002046.

Study type: Cochrane systematic review

What it established: Cochrane reviews are considered the highest tier of evidence synthesis in medical research. The 2005 review on low level laser therapy for osteoarthritis examined published randomized controlled trials and concluded that the evidence at the time was mixed. Some studies showed benefit, others did not, and methodological quality varied. The review called for higher-quality randomized controlled trials before drawing definitive conclusions (Cochrane Library).

What it does not prove: The Cochrane review does not say photobiomodulation does not work. It says, accurately, that the evidence base is incomplete and inconsistent. Subsequent reviews and trials have continued to add evidence on both sides.

Why every operator should know this study: This is the citation that prevents overclaiming. An operator who can quote a Cochrane review and explain that the evidence base is still developing builds more credibility than one who cherry picks favorable studies. The Cochrane review is the antidote to marketing copy that overstates the science.

[INFOGRAPHIC: The 5 Foundational Photobiomodulation Studies Every Operator Should Know]

How do these five studies compare side by side?

How should an operator reference research without making product claims?

This is the practical question that determines whether marketing copy is compliant or exposed.

The clean structure follows three rules.

Rule one: attribute findings to research, not to the device. "Published research suggests that photobiomodulation may support cellular energy production" is compliant. "Our red light therapy bed boosts cellular energy" is not. The first describes peer-reviewed evidence. The second is a product claim outside ILY scope.

Rule two: cite specific studies with full URLs. A reference to "studies show" or "research suggests" without a citation is weak both rhetorically and legally. A specific citation with author, year, journal, and URL is verifiable, defensible, and demonstrates earned authority.

Rule three: state the limit of the evidence. When a study supports a finding in muscle tissue, do not extend the claim to whole-body benefits. When a study is small, say it is small. The operator who acknowledges limits is more credible than the one who hides them.

For a deeper breakdown of FDA registered scope and the difference between research and product claims, see our companion post on What FDA Registered Actually Means in Red Light Therapy.

What does this body of evidence mean for Body Balance System and the OvationULT?

Body Balance System is FDA registered under registration number 3010627475, with the OvationULT listed under the ILY product code for infrared lamp heating. Within ILY scope, the device is described accurately for topical heating, temporary relief of minor muscle and joint pain and stiffness, temporary relief of minor arthritis pain, relaxation of muscle spasm, and temporary increase of local circulation.

Beyond ILY scope, the OvationULT is not marketed as a treatment for specific diseases or conditions. The published research above is referenced as research, not as evidence that any one device treats anything. This is the operating discipline an FDA registered manufacturer is required to maintain, and the same discipline operators should expect from any manufacturer they evaluate.

The OvationULT delivers 65 milliwatts per square centimeter at the contact surface across both red and near-infrared wavelength bands, with full body coverage and 12 to 20 minute session protocols calibrated to published dose response evidence. The 5 year white glove warranty supports commercial deployment in medspas, gyms, recovery centers, and hospitality spas at properties including the Bellagio, Aria, Four Seasons, Fairmont, and Canyon Ranch.

FAQ

How many peer-reviewed studies exist on red light therapy?

PubMed currently indexes more than 7,000 papers on photobiomodulation, the technical term for red and near-infrared light therapy at therapeutic wavelengths. The volume continues to grow, with new studies appearing every week.

Are the published studies all human trials?

No. The literature includes cell culture work, animal model studies, and human clinical trials. The strongest evidence for any specific application is randomized controlled trials in humans, but those represent a minority of the total literature.

Can an operator cite published research in marketing without FDA exposure?

Yes, when done correctly. Attributing findings to the research, citing specific studies with URLs, and not extending those findings into product claims about the operator's specific device keeps the citation within compliant scope.

What is the difference between a single study and a systematic review?

A single study reports one experiment with one population. A systematic review evaluates many studies on the same question and synthesizes the combined evidence. Cochrane reviews and other systematic reviews are considered higher tier evidence than individual studies.

Should an operator quote studies during client consultations?

Selectively. Citing one or two foundational studies builds credibility. Reciting a literature review during a consultation overwhelms the client. The best practice is to know the studies well enough to answer questions when they come up, not to lead with them.

Internal Links

How Does Red Light Therapy Work? A Manufacturer's Guide to Photobiomodulation

What FDA Registered Actually Means in Red Light Therapy

The Complete Guide to Commercial Red Light Therapy

How to Add Red Light Therapy to Your Medspa

External Citations

Karu, T. (1999). Primary and secondary mechanisms of action of visible to near-IR radiation on cells. Journal of Photochemistry and Photobiology B

Huang, Y. Y. et al. (2009). Biphasic dose response in low level light therapy. Dose-Response

Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics

Ferraresi, C. et al. (2016). Photobiomodulation in human muscle tissue. Journal of Biophotonics

Brosseau, L. et al. (2005). Low level laser therapy for osteoarthritis. Cochrane Database of Systematic Reviews

FTC Health Products Compliance Guidance

Equipment cost: $55,000 (OvationULT Zero Gravity Bed)

Conservative case: $75/session x 6 sessions/day x 25 days = $11,250/month gross. Payback at 4.9 months.

Moderate case: $100/session x 8 sessions/day x 25 days = $20,000/month gross. Payback at 2.75 months.

Annual revenue range (year 1, moderate utilization, no membership): $96,000–$216,000. At a medspa where existing staff handle client intake and the bed operates with minimal supervision, marginal cost per session is low: primarily linens, cleaning solution, and a fraction of front-desk time.

What Should You Look for When Evaluating Commercial Red Light Therapy Equipment?

The difference between a consumer-grade product and a purpose-built commercial device determines whether you run 2 clients per hour or wait 20 minutes between sessions for the unit to cool down.

Commercial Equipment Evaluation Framework

The OvationULT Zero Gravity Bed against this framework: 65 mW/cm² irradiance at body surface (measured at 2–3" client proximity), 28,443 total diodes (22,755 x 635 nm red + 5,688 x 850 nm NIR), standard 3-prong outlet, 30-second cleanup protocol, 175 lbs, FDA-registered Class II device (Registration #3010627475, Device Listing #877966, Product Code ILY, 21 CFR 890.5500), SGS North America NRTL certified, 5-year white-glove warranty, manufactured in Las Vegas, NV.

How Does the Membership Model Change the Revenue Math?

Per-session revenue is a floor, not a ceiling. A client purchasing a $299/month membership for 8 sessions generates $3,588/year in guaranteed recurring revenue, compared to $1,560 if they visit quarterly as a single-session client.

Membership vs. Single-Session Revenue: 12-Month Comparison

Session-equivalent pricing reflects the cost per session embedded in each tier. Membership economics favor the operator on both revenue and retention.

Membership Pricing Architecture

Entry-level ($149–$199/month): 4–8 sessions/month. Minimal friction for clients already spending $300–$500/month on other services.

Active ($249–$299/month): 12–16 sessions/month. These clients drive referral traffic and carry the highest lifetime value.

Add-on bundle: RLT membership paired with one facial or discounted injectables. Locks in multi-service revenue while making the math compelling for the client.

For room setup details, staff training protocols, and a full marketing playbook, see our complete operator's guide.

What Compliance Obligations Apply to Red Light Therapy in a Medspa?

When marketing red light therapy, stay within general wellness claims. For FDA-registered Class II devices with an ILY product code, cleared indications include temporary relief of minor muscle and joint pain, relaxation of muscle spasm, and temporary increase of local circulation. Do not claim RLT treats, cures, or prevents named medical conditions, and avoids implying specific therapeutic outcomes in before/after photography. Have your medical director or legal counsel review consent documentation and marketing language against FTC guidelines and your state's medspa regulations. In most states, FDA-registered Class II PBM beds do not require elevated physician involvement compared to other non-ablative devices, but state-by-state variation exists.

Frequently Asked Questions

How much space does a commercial red light therapy bed require?

Plan for 100–120 sq ft. The bed footprint is approximately 80–85 inches long by 36–40 inches wide. You need clearance on all sides for client entry and exit, plus space for a small side table. Standard 8-foot ceilings and existing HVAC are sufficient.

Can red light therapy be combined with other medspa services?

Yes. RLT is commonly positioned before or after facials, and in the 24–48 hours following injectable appointments as a recovery-supportive service. There are no known adverse interactions with standard medspa services at therapeutic intensities. Train staff to discuss combinations at every applicable appointment.

What is the typical utilization rate in the first 90 days?

Most operators see 30–50% utilization in the first 90 days as they build awareness and a membership base. With consistent marketing to existing clients and front-desk prompting at every applicable appointment, 60–75% utilization by month 4–6 is achievable. At 50% utilization and $100/session, a single bed generates $15,000/month gross.

Do you need a medical director specifically for red light therapy?

This varies by state. FDA-registered Class II commercial PBM beds are generally categorized as general wellness devices, not medical procedures. Review your state's medspa statute and your existing medical director agreement. Most states do not require an elevated level of physician involvement for RLT compared to other non-ablative devices.

How do I explain red light therapy to a client who has never tried it?

Keep it direct: "It's a 10–15 minute full-body session in a bed that emits specific wavelengths of red and near-infrared light. The light interacts with your cells at the mitochondrial level, signaling them to produce more energy. Most clients use it for recovery, relaxation, and overall wellness. No heat, no downtime, you're out the door immediately after." Avoid clinical language that implies disease treatment.

Citations

Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics. 2017;4(3):337-361. doi: 10.3934/biophy.2017.3.337. PMID: 28748217. https://pubmed.ncbi.nlm.nih.gov/28748217/ 

Ferraresi C, Huang YY, Hamblin MR. Photobiomodulation in human muscle tissue: an advantage in sports performance? J Biophotonics. 2016;9(11-12):1273-1299. doi: 10.1002/jbio.201600176. PMID: 27874264. https://pubmed.ncbi.nlm.nih.gov/27874264/ 

Avci P, Gupta A, Sadasivam M, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg. 2013;32(1):41-52. PMID: 24049929. https://pmc.ncbi.nlm.nih.gov/articles/PMC4126803/ 

FDA Device Registration #3010627475. Device Listing #877966. Product Code ILY. Classification: 21 CFR 890.5500. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm 

Body Balance System has manufactured commercial red light therapy equipment in Las Vegas, NV for 13 years. The OvationULT Zero Gravity Bed is an FDA-registered Class II device (Registration #3010627475, Device Listing #877966, Product Code ILY, 21 CFR 890.5500), certified by SGS North America (NRTL), and installed in properties including the Four Seasons Beverly Wilshire, Four Seasons Hong Kong, Bellagio, and Aria.